Filter
1707
Text search:
Public
Health
laboratory
service
network
Featured
193
537
Language
Document type
935
263
239
118
93
19
18
17
2
1
1
Countries / Regions
87
65
63
61
60
56
53
44
41
37
32
29
28
26
26
26
24
22
21
19
19
19
18
17
16
16
16
15
14
14
13
12
11
9
9
8
8
8
7
7
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
778
118
96
89
41
36
15
Toolboxes
170
138
126
92
63
49
43
43
37
34
33
33
32
28
25
18
17
16
16
15
15
13
12
11
1
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as tech
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Accessed November, 2017
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was a
...
There has never been a more critical moment to invest in WHO, and strengthen the unique role it plays in global health. Now is the time to sustainably finance WHO and invest in a healthy return for all.
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
WHO/CDS/TB/99.272
A manual for programme managers.
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Update 2021; Immunization, Vaccines and Biologicals
10–11 May 2016, Catania, Italy
